Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospin...

Boronic Acid‐Rich Lanthanide Metal‐Organic Frameworks Enable Deep Proteomics with Ultratrace Biological Samples

S Zhang, B Ghalandari, Y Chen, Q Wang… - Advanced …, 2024 - Wiley Online Library

Label‐free proteomics is widely used to identify disease mechanism and potential
therapeutic targets. However, deep proteomics with ultratrace clinical specimen remains a …

[HTML][HTML] Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer's disease? An umbrella review

H Mohammadi, A Ariaei, Z Ghobadi… - IBRO Neuroscience …, 2024 - Elsevier

Biomarkers are measured to evaluate physiological and pathological processes as well as
responses to a therapeutic intervention. Biomarkers can be classified as diagnostic …

Hybrid Membrane‐Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease

RR Lin, LL Jin, YY Xue, ZS Zhang, HF Huang… - Advanced …, 2024 - Wiley Online Library

The blood brain barrier (BBB) limits the application of most therapeutic drugs for
neurological diseases (NDs). Hybrid cell membrane‐coated nanoparticles derived from …

[HTML][HTML] Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease

X Wang, X Zhang, J Liu, J Zhang, C Liu, Y Cui… - Alzheimer's Research & …, 2024 - Springer

Background Previous studies have demonstrated that early intervention was the best plan to
inhibit the progression of Alzheimer's disease (AD), which relied on the discovery of early …

[HTML][HTML] Prevalence and risk factors for dementia and mild cognitive impairment among older people in Southeast China: a community-based study

B Jiang, Q Liu, JP Li, SN Lin, HJ Wan, ZW Yu, J Wang… - BMC geriatrics, 2024 - Springer

Background With the aging population, the number of individuals with dementia in China is
increasing rapidly. This community-based study aimed to investigate the prevalence and risk …